News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories renews agreement with Jamia Hamdard University cementing the industry-academia collaboration to enable affordable vaccine development

Date: 13/12/2014

Hilleman Laboratories renews agreement with Jamia Hamdard University cementing the industry-academia collaboration to enable affordable vaccine development

Hilleman Laboratories, an equal joint-venture partnership between Merck & Co. and Wellcome Trust, and Jamia Hamdard University sign an agreement to renew their lease for another 4 years (January 2015 – December 2018) furthering their efforts towards Vaccine Research and Training Capacity Building.

View All